Fig. 2 (Panel A) demonstrated ~50% increase in p-p38 MAP kinase in the retina from the diabetic mice, which was completely abrogated in diabetic mice receiving NSC23766, an inhibitor of Tiam1-Rac1 signaling pathway, soon after induction of diabetes. This evidence concerns the gene MAPK14 and diabetes mellitus.